Pharmafile Logo
Pharmafocus logo
Advanced Search

Vaccine

Showing 15 posts of 293 posts found.

shutterstock_38078521

AstraZeneca and Oxford Uni’s COVID-19 vaccine trial resumes following safety review

September 14, 2020
Research and Development, Sales and Marketing AstraZeneca, COVID-19, Oxford University, Vaccine

After sparking a wave of concern through industry and mainstream media with the news it had halted international studies investigating …

News
800px-pfizer_finland_hq_february_13_2009

Pfizer CEO says company’s COVID-19 vaccine will be available this year if FDA approves the candidate by October

September 14, 2020
Sales and Marketing Pfizer, Pfizer vaccine, Vaccine

Albert Bourla, the CEO of Pfizer, has said that the company’s vaccine for COVID-19 could be used by the general …

News
800px-astrazeneca_hq_in_cambridge_uk

AstraZeneca Chief Executive says vaccine is still possible this year

September 10, 2020
Research and Development AstraZeneca, Oxford Vaccine, Vaccine, coronavirus vaccine, vaccines

Pascal Soriot, Chief Executive of AstraZeneca, said that the company’s vaccine could still be available this year, despite the clinical …

News
800px-rhesus_macaque_monkey_the_look

Pfizer-BioNTech reports strong immune response in animals to its COVID-19 vaccine

September 10, 2020
Research and Development COVID, Macaques, Monkey, Vaccine

Pfizer-BioNTech announced Wednesday that preliminary preclinical data from mouse and macaque monkey models showed a strong immune response from its …

News
800px-thumbnail_1

Up to 60,000 in the UK may have suffered from “long COVID” new data suggests

September 8, 2020
Manufacturing and Production Vaccine, pandemic, vaccines

60,000 people across Britain may have been suffering from prolonged symptoms of coronavirus months after contracting the virus. This is …

News
800px-vaccine

Sanofi halts Phase 3 trial of Kevzara as a COVID-19 treatment

September 1, 2020
Manufacturing and Production COVID-19, Sanofi, Vaccine, pharma

Sanofi is halting clinical trials treating serious COVID-19 patients with its Kevzara drug after data on its efficacy proved inconclusive.The …

News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

August 28, 2020
Medical Communications COVID-19, Vaccine, coronavirus vaccine, top 10

The top 10 news stories this week are focused on coronavirus vaccines and treatments, as China is set to move …

News
1_hpv_vaccine

AstraZeneca begins antibody COVID-19 treatment trial in the UK

August 25, 2020
Manufacturing and Production Vaccine, coronavirus

AstraZeneca has started a clinical trial of its antibody treatment designed to prevent and also treat symptoms of coronavirus. The …

News
china_v

China’s ‘insect’ vaccine for COVID-19 approved for human testing

August 24, 2020
Sales and Marketing COVID, Vaccine, coronavirus

China is set to move ahead with human testing of a potential coronavirus vaccine that has been created using insect …

News
moderna

Moderna commits 100 million COVID-19 vaccine doses to the US

August 12, 2020
Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, Moderna, US, Vaccine, pharma

Moderna continues to rise to meet the demands of the pandemic, signing a new deal with the US Government to …

News
vxxxxeer

Russia becomes world’s first country to grant regulatory approval for a coronavirus vaccine

August 11, 2020
Manufacturing and Production COVID, COVID-19, Vaccine, coronavirus

President Putin has announced that Russia is the first country to grant regulatory approval for a COVID-19 vaccine. The final …

News
novavax

Novavax inks deal to deliver one billion COVID-19 vaccine doses in India and other regions

August 10, 2020
Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, India, Novavax, Serum Institute of India Private Limited, Vaccine

Novavax is partnering up with the Serum Institute of India Private Limited (SIIPL) in a licensing deal to development and …

News
vaccination-1215279_960_720

Early promise from Novavax’s vaccine candidate for COVID-19

August 7, 2020
Medical Communications, Research and Development COVID-19, Novavax, Vaccine

New Phase 1/2 on Novavax’s COVID-19 vaccine candidate NVX‑CoV2373 has shown that the therapy generated “robust antibody responses” when used …

News
duma

Russia claims it will start mass immunisation with a COVID-19 vaccine from October

August 4, 2020
Manufacturing and Production Russia, Vaccine, putin

The Russian government is claiming it will start production of a viable coronavirus vaccine candidate next month and begin the …

News
sanofi_hq

Sanofi indicted on manslaughter charges over its epilepsy drug Depakine

August 4, 2020
Manufacturing and Production Sanofi, Vaccine

Sanofi is being investigated for manslaughter in France over the deaths of four babies whose mothers took its anti-epilepsy medication …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026